- Brand IP Statement(s) re: (c), (TM), (SM)
- In a clinical study of postmenopausal women with low estrogen levels, Ostera(TM)-in conjunction with a modified Mediterranean, low glycemic diet and regular exercise-was shown to beneficially influence key markers of bone remodeling more than diet and exercise alone. Bone remodeling is the natural process of healthy breakdown and formation of the bone matrix-the structure where minerals are deposited. This scientifically advanced formula features selective kinase response modulators (SKRMs) in the form of RIAA, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process.
- Suggested/Recommended/Usage/Directions
- Recommended for use with Cal Apatite(R)-an advanced bioactive formulation for bone mineralization.
- FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Storage
- STORAGE: Keep tightly closed in a cool, dry place.
- Formulation re: Does NOT Contain
- This product is Gluten Free.
- General Statements: All Other Content
- Genetic Potential Through Nutrition
- Seals/Symbols
- UNLEASHING THE POWER OF NUTRAGEMICS
ExpressSyn(TM)
- Formula re: Type
- Promotes Healthy Bone Remodeling in Postmenopausal Women
- General Statements: All Other Content
- with Selective Kinase Response Modulators
- FDA Statement of Identity
- Dietary Supplement
- General Statements: All Other Content